Page 4 - Rick Eiswirth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ALIM earnings call for the period ending September 30, 2021.

Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to Alimera Sciences' First Quarter Fiscal Year 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded by a playback-purposes. A webcast replay of the call will be available approximately one hour after the end of the call through May 13, 202...

Alimera Sciences Continues to Execute on Its Expansion Strategy in Denmark and Luxembourg, and Achieves Extended Reimbursement in Ireland March 17, 2021 08:00 ET | Source: Alimera Sciences, Inc. Alimera Sciences, Inc. Alpharetta, Georgia, UNITED STATES ATLANTA, March 17, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces continued execution on its ...

Alimera Sciences Continues to Execute on Its Expansion Strategy in Denmark and Luxembourg, and Achieves Extended Reimbursement in Ireland March 17, 2021 08:00 ET | Source: Alimera Sciences, Inc. Alimera Sciences, Inc. Alpharetta, Georgia, UNITED STATES ATLANTA, March 17, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces continued execution on its ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for ... Alimera Sciences, Inc.February 18, 2021 GMT ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, announces that ILUVIEN is now available in Finland for diabetic macular edema (DME) and non-infectious uveitis affecting the posterior segment (...